Serum IP-10 as a Biomarker of Human Rhinovirus Infection at Exacerbation of COPD
- 1 April 2010
- Vol. 137 (4) , 812-822
- https://doi.org/10.1378/chest.09-1541
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (RO1 HL082578)
This publication has 36 references indexed in Scilit:
- Temporal Clustering of Exacerbations in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2009
- New anti-viral drugs for the treatment of the common coldBioorganic & Medicinal Chemistry, 2008
- RSV604, a Novel Inhibitor of Respiratory Syncytial Virus ReplicationAntimicrobial Agents and Chemotherapy, 2007
- Comparison of Results of Detection of Rhinovirus by PCR and Viral Culture in Human Nasal Wash Specimens from Subjects with and without Clinical Symptoms of Respiratory IllnessJournal of Clinical Microbiology, 2007
- Differential Chemokine Expression following Respiratory Virus Infection Reflects Th1- or Th2-Biased ImmunopathologyJournal of Virology, 2006
- Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infectionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2005
- An Immune Basis for Lung Parenchymal Destruction in Chronic Obstructive Pulmonary Disease and EmphysemaPLoS Medicine, 2004
- Regulation of TNF‐α and IFN‐γ induced CXCL10 expression: participation of the airway smooth muscle in the pulmonary inflammatory response in chronic obstructive pulmonary diseaseThe FASEB Journal, 2003
- Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary diseaseThorax, 1998
- Basic principles of ROC analysisSeminars in Nuclear Medicine, 1978